Kewaunee reports weaker sales: Kewaunee Scientific stock is 26.67 percent below high

Published on 10/05/2026 at 12:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sales fell 6.70 percent to USD 66.32 million in fiscal 2027 first quarter. Kewaunee Scientific stock costs EUR 30.50 on October 5, 2026 versus EUR 30.40.

KEQU, US4928541048, Illustration mit AI erstellt.

Kewaunee Scientific (ISIN US4928541048) was trading at EUR 30.50 at Lang & Schwarz on October 5, 2026 at 12:01 p.m. CEST, plus 0.33 percent versus the prior close of EUR 30.40. On the Nasdaq, KEQU was USD 34.16 on October 2, 2026, 26.67 percent below its USD 46.57 52-week high, while fiscal 2027 first-quarter sales fell to USD 66.32 million.

Fiscal 2027 sales decline

As Morningstar reported on September 9, 2026, Kewaunee Scientific's sales in the first quarter of fiscal 2027 decreased 6.70 percent from USD 71.10 million in the prior-year quarter. Net earnings attributable to the company fell to USD 1.71 million from USD 3.09 million, while diluted earnings per share declined to USD 0.58 from USD 1.04.

Morningstar also reported that fiscal 2027 first-quarter EBITDA, a non-GAAP measure, fell to USD 4.53 million from USD 6.32 million. The figures point to weaker quarterly volume, not a balance-sheet shock, because the company entered the period with a sizeable project backlog.

International margins offset pressure

Order backlog stood at USD 169.00 million on July 31, 2026, up from USD 165.90 million on April 30, 2026 but below USD 205.00 million a year earlier, according to Morningstar.

The international segment supplied the counterweight in the first quarter of fiscal 2027. Morningstar reported international sales down 7.80 percent to USD 15.45 million, yet segment net earnings rose 23.50 percent to USD 0.79 million. That combination makes mix and project timing central to the next quarterly comparison.

KEQU price stays below high

KEQU was trading at EUR 30.50 at Lang & Schwarz on October 5, 2026 at 12:01 p.m. CEST, plus 0.33 percent versus the Lang & Schwarz prior close of EUR 30.40 on October 2, 2026. Its primary-market reference was USD 34.16 on the Nasdaq on October 2, 2026, against a 52-week range of USD 32.00 to USD 46.57.